Department of Thyroid Surgery, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou Jiangsu, 213000, China.
Department of General Surgery, Changzhou Hospital of Traditional Chinese Medicine, Changzhou Jiangsu, 213000, China.
World J Surg Oncol. 2024 Jun 5;22(1):148. doi: 10.1186/s12957-024-03433-2.
Gasless transaxillary endoscopic thyroidectomy (GTET) and endoscopic thyroidectomy via the areola approach (ETA) have emerged as minimally invasive surgical techniques for managing papillary thyroid carcinoma (PTC). This study aimed to assess the surgical efficacy of endoscopic thyroidectomy (ET) as compared to conventional open thyroidectomy (COT) in PTC patients.
Between 2020 and 2022, 571 PTC patients underwent unilateral thyroidectomy accompanied by ipsilateral central lymph node dissection. This cohort comprised 72 patients who underwent GTET, 105 ETA, and 394 COT. The analysis encompassed a comprehensive examination of patient clinicopathologic characteristics and postoperative complaints. Furthermore, the learning curve of GTET was evaluated using the cumulative summation (CUSUM) method.
Patients in the ET group exhibited a lower mean age and a higher proportion of female individuals. Operation time in the ET group was significantly longer. No significant differences were observed in the incidence of postoperative complications among the three groups. With regard to postoperative complaints reported three months after surgery, GTET demonstrated superior alleviation of anterior chest discomfort and swallowing difficulties. Patients who underwent ET reported significantly higher cosmetic satisfaction levels. Additionally, the learning curve of GTET was 27 cases, and the operation time during the mature phase of the learning curve exhibited a significant reduction when compared to ETA.
The findings of this study affirm the safety and feasibility of employing GTET and ETA for the surgical management of PTC. GTET presents an attractive surgical option, particularly for patients with unilateral PTC who place a premium on cosmetic outcomes.
无气经腋窝内镜甲状腺切除术(GTET)和乳晕入路内镜甲状腺切除术(ETA)已成为治疗甲状腺乳头状癌(PTC)的微创外科技术。本研究旨在评估与传统开放甲状腺切除术(COT)相比,内镜甲状腺切除术(ET)在 PTC 患者中的手术效果。
2020 年至 2022 年期间,571 例 PTC 患者接受单侧甲状腺切除术和同侧中央淋巴结清扫术。该队列包括 72 例行 GTET、105 例行 ETA 和 394 例行 COT 的患者。分析包括对患者临床病理特征和术后并发症的全面检查。此外,使用累积和(CUSUM)方法评估 GTET 的学习曲线。
ET 组患者的平均年龄较低,女性比例较高。ET 组的手术时间明显更长。三组患者术后并发症发生率无显著差异。术后 3 个月报告的术后并发症方面,GTET 在前胸部不适和吞咽困难的缓解方面表现出优越性。接受 ET 的患者报告的美容满意度明显更高。此外,GTET 的学习曲线为 27 例,学习曲线成熟阶段的手术时间与 ETA 相比显著缩短。
本研究结果证实了 GTET 和 ETA 用于治疗 PTC 的安全性和可行性。GTET 是一种有吸引力的手术选择,特别是对于单侧 PTC 患者,他们更关注美容效果。